Related by context. All words. (Click for frequent words.) 73 Satraplatin 69 valopicitabine 69 perifosine 69 picoplatin 68 Marqibo 68 carfilzomib 68 Vectibix 68 FOLOTYN 68 Amrubicin 67 panitumumab 67 OPAXIO 66 telbivudine 66 apaziquone 66 talactoferrin 66 Advexin 66 clofarabine 65 pralatrexate 65 BAY #-# 65 ERBITUX 65 T DM1 65 elotuzumab 65 Nexavar 65 AP# [003] 65 Clolar 65 vandetanib 65 Erbitux 65 glufosfamide 64 ixabepilone 64 Dacogen 64 ridaforolimus 64 amrubicin 64 ADVEXIN 64 Targretin 64 IMGN# 64 TELCYTA 64 PXD# 64 L BLP# 64 MGCD# [001] 64 Fodosine 64 Taxotere R 64 Folotyn 64 fidaxomicin 64 oral ridaforolimus 64 brentuximab vedotin 64 Tarceva 64 TREANDA 63 Taxotere ® 63 HGS ETR1 63 Erbitux cetuximab 63 ASA# 63 linaclotide 63 Alpharadin 63 forodesine 63 sorafenib 63 axitinib 63 Nexavar ® 63 EOquin 63 aflibercept 63 Zerenex 63 blinatumomab 63 Perifosine 63 tivozanib 63 Afinitor 63 alvimopan 63 Ixempra 63 Ceplene 63 phase IIb clinical 63 DAVANAT R 63 CoFactor 63 Proxinium TM 63 ofatumumab 63 #D#C# 63 Virulizin R 63 denosumab 62 Icatibant 62 Civacir 62 telaprevir 62 SinuNase 62 Treanda 62 INTELENCE 62 FTY# 62 ambrisentan 62 dabigatran etexilate 62 Plenaxis R 62 Allovectin 7 R 62 teduglutide 62 PROMACTA 62 ipilimumab 62 tanespimycin 62 cinacalcet HCl 62 nimotuzumab 62 pirfenidone 62 eltrombopag 62 Troxatyl 62 ceftobiprole 62 Abraxane 62 Allovectin 7 62 INCB# [002] 62 TELINTRA 62 Zevalin 62 ozarelix 62 pixantrone 62 XL# [003] 61 ABRAXANE 61 eniluracil 61 mapatumumab 61 Genasense 61 TYZEKA 61 ZEVALIN 61 EFAPROXYN 61 YERVOY 61 XGEVA 61 EOquin TM 61 Phenoptin 61 BiovaxID 61 atacicept 61 Yondelis 61 Urocidin 61 VELCADE 61 sorafenib tablets 61 BENLYSTA 61 Stimuvax 61 investigational compound 61 YONDELIS 61 Revlimid 61 pomalidomide 61 ruxolitinib 61 ZYBRESTAT 61 Asentar 61 PREOS 61 dacetuzumab 61 Mepact 61 JAK inhibitor 61 voclosporin 61 bazedoxifene 61 temsirolimus 61 methylnaltrexone 61 NEBIDO 61 RAD# [003] 61 bone metastases 61 dirucotide 61 tesmilifene 61 custirsen 61 zalutumumab 61 Ranexa 61 Entereg 61 RSR# 61 PEG INTRON 61 tamibarotene 60 Velcade 60 Allovectin 7 ® 60 XYOTAX 60 abiraterone acetate 60 docetaxel 60 Dacogen injection 60 registrational 60 febuxostat 60 Femara 60 TORISEL 60 lapatinib 60 Velcade bortezomib 60 Junovan 60 Tarceva TM 60 ocrelizumab 60 subcutaneous formulation 60 APF# 60 Jevtana 60 Xcytrin 60 afatinib 60 GPC Biotech 60 Tavocept 60 deforolimus 60 R sorafenib tablets 60 HuMax CD4 60 TEMODAL 60 TRISENOX 60 Hycamtin 60 ISENTRESS 60 pradefovir 60 Panzem 60 Vidaza 60 alvespimycin 60 Vectibix panitumumab 60 docetaxel Taxotere R 60 registrational trial 60 Canvaxin 60 Zactima 60 Bonefos 60 pitavastatin 60 Orazol 60 Tasigna 60 HER2 positive metastatic breast 60 Ceflatonin 60 toremifene 60 ponatinib 60 celgosivir 60 Tarceva erlotinib 60 Xyotax 60 TYKERB 60 Taxotere docetaxel 60 Campath 60 MabCampath 60 MBP# [001] 60 ELND# 60 MEPACT 60 Phase III clinical trials 60 Zalbin 60 thymalfasin 60 NOXAFIL 60 Arixtra 60 TMC# [001] 60 palonosetron 60 LIALDA 60 Oncophage 60 regadenoson 60 ONCONASE 60 teriflunomide 60 romiplostim 60 peginesatide 60 IRX 2 60 VIDAZA 60 lubiprostone 60 ZADAXIN 60 sunitinib malate 60 PROVENGE 60 Fludara 60 daclizumab 59 RG# [001] 59 Telavancin 59 enzastaurin 59 Onconase 59 TOCOSOL Paclitaxel 59 ustekinumab 59 romidepsin 59 Theratope 59 Belinostat 59 Ambrisentan 59 oral deforolimus 59 MOZOBIL 59 ZK EPO 59 FOLOTYN ® 59 Amigal 59 relapsed multiple myeloma 59 Archexin 59 Azixa 59 dalbavancin 59 maribavir 59 azacitidine 59 neratinib 59 dasatinib 59 Virulizin 59 Sebivo 59 DU #b 59 Nuvion 59 FOSRENOL 59 Cethrin 59 huC# DM4 59 NDA submission 59 Azilect ® 59 erlotinib 59 refractory multiple myeloma 59 docetaxel Taxotere ® 59 HspE7 59 AZILECT R 59 albinterferon alfa 2b 59 TYSABRI 59 Pirfenidone 59 belinostat 59 nilotinib 59 Bortezomib 59 Phase Ib 59 Raptiva ® 59 REOLYSIN ® 59 Firazyr 59 Panzem R NCD 59 investigational drug 59 CAELYX 59 IRESSA 59 PLX# 59 temozolomide 59 Hematide 59 Riquent 59 Gemzar 59 ELACYT 59 Nexavar sorafenib 59 lorvotuzumab mertansine 59 Diamyd ® 59 ISTODAX 59 taxane 59 Phase III clinical 59 Orathecin 59 obatoclax 59 Anturol 59 ZOLINZA 59 Actemra 59 Zelrix 59 Onco TCS 59 voreloxin 59 Dyloject 59 Azedra 59 LEVADEX 59 entinostat 59 Phase 2b trial 59 elagolix 59 SEBIVO 59 Zolinza 59 anticancer compound 58 Raptiva R 58 Bezielle 58 Bronchitol 58 UPLYSO 58 Exalgo 58 icatibant 58 rhThrombin 58 taliglucerase alfa 58 Combidex 58 Avastin bevacizumab 58 bendamustine 58 refractory Hodgkin lymphoma 58 REMICADE ® 58 carboplatin 58 cilengitide 58 vinorelbine 58 Nebido 58 Telintra 58 Phase 2b clinical 58 Lialda 58 monotherapy 58 OvaRex ® MAb 58 Cellegesic 58 GATTEX 58 Tocosol Paclitaxel 58 SNT MC# 58 bicifadine 58 rindopepimut 58 regorafenib 58 PhosLo 58 Telcyta 58 zanolimumab 58 ZENPEP 58 forodesine hydrochloride 58 Genasense ® 58 Cladribine Tablets 58 Mylotarg 58 metastatic renal cell carcinoma 58 Zensana 58 Viramidine 58 Laquinimod 58 orphan designation 58 ceftaroline 58 Pegintron 58 lintuzumab 58 ThermoDox R 58 AQ4N 58 Teysuno 58 Æterna Zentaris 58 dose cohorts 58 PF # [001] 58 DAVANAT 58 oral methylnaltrexone 58 Pennsaid R 58 IL# PE#QQR 58 FavId 58 gefitinib 58 tocilizumab 58 vemurafenib 58 Omigard 58 Xinlay 58 rilpivirine 58 Xanafide 58 veltuzumab 58 Cloretazine ® 58 Loramyc R 58 Sensipar 58 TNFerade 58 orBec R 58 cintredekin besudotox 58 angioedema indications 58 Promacta 58 ProLindac 58 Defibrotide 58 iloperidone 58 LEP ETU 58 Ereska 58 Kuvan 58 SPRYCEL 58 Aurexis 58 pivotal Phase III 58 phase IIb 58 gemcitabine 58 golimumab 58 Torisel 58 ganetespib 58 MAGE A3 ASCI 58 vicriviroc 58 alogliptin 58 Increlex R 58 DAVANAT ® 58 otelixizumab 58 zoledronic acid 58 Sprycel 58 OMAPRO 58 HGS# 58 Pfizer Sutent 58 Multikine 58 trastuzumab DM1 T DM1 58 STELARA 58 Cotara 58 Aclasta 58 Plenaxis TM 58 LAF# 58 ELIQUIS 58 Traficet EN 58 Vandetanib 58 Corlux 58 Cimzia 58 Rapinyl 58 vilazodone 58 ONTAK 58 Taxotere 58 erlotinib Tarceva 58 Vicinium TM 58 Solasia 58 Bicifadine 58 Aflibercept 58 cetuximab Erbitux 58 Reverset 58 Emselex 58 carboplatin paclitaxel 58 MNTX 58 BRIM3 58 bevacizumab Avastin 58 silodosin 58 topotecan 58 Onalta 58 ASONEP 58 indolent NHL 58 chemotherapeutic agent 58 Gemzar ® 58 trabectedin 58 phase IIa clinical 58 panitumumab Vectibix 58 Halaven 58 Acapodene 58 AEG# 58 Preotact 58 AEGR 58 sapacitabine 58 rALLy trial 57 orphan drug 57 torezolid phosphate 57 GVAX immunotherapy 57 Reolysin 57 Mimpara 57 Evoltra TM 57 Fodosine TM 57 IMC A# 57 Herceptin trastuzumab 57 GVAX 57 mipomersen 57 Pazopanib 57 entecavir 57 clevudine 57 palifermin 57 HRPC 57 TYGACIL 57 velaglucerase alfa 57 RELISTOR 57 REVLIMID 57 decitabine 57 Desmoteplase 57 TheraCIM 57 elinogrel 57 edoxaban 57 bosutinib 57 Phase Ib study 57 HuMax EGFr 57 everolimus 57 ZACTIMA 57 HuMax CD# 57 PDE4 inhibitor 57 ZADAXIN ® 57 iniparib 57 sorafenib Nexavar 57 asenapine 57 Increlex ® 57 Catena ® 57 mitoxantrone 57 Orphan Drug Designation 57 relapsed refractory multiple myeloma 57 Gefitinib 57 Imprime PGG 57 bortezomib 57 rivaroxaban 57 platinum refractory 57 vismodegib 57 Insegia 57 SIMPONI 57 rNAPc2 57 radiation sensitizer 57 reslizumab 57 CR# vcMMAE 57 adecatumumab 57 Stimuvax R 57 Phase IIIb clinical 57 PTK ZK 57 RITUXAN 57 Panzem R 57 Indaflex TM 57 elesclomol 57 BEXXAR 57 Ceplene R 57 PEP# [003] 57 Abstral 57 palifosfamide 57 QAB# 57 cutaneous T cell 57 MEK inhibitors 57 abiraterone 57 Tykerb 57 nitazoxanide 57 Biologics License Application 57 Ventavis 57 NVA# 57 tolevamer 57 Cimzia ® 57 Bexxar 57 motavizumab 57 vinflunine 57 fluoropyrimidine 57 INCB# [001] 57 Tamibarotene 57 docetaxel Taxotere 57 Panitumumab 57 Dyloject TM 57 PLK1 SNALP 57 Revlimid lenalidomide 57 relapsed ovarian cancer 57 Rhucin ® 57 Fusilev 57 Xarelto 57 Phase 2a trial 57 IMA# 57 MyVax personalized immunotherapy 57 frovatriptan 57 Dasatinib 57 supplemental biologics 57 Plicera 57 MORAb 57 PREZISTA r 57 Gleevec Glivec 57 LY# [003] 57 Irinotecan 57 Phase III pivotal 57 VIMOVO 57 sunitinib 57 AVASTIN 57 vorinostat 57 Marketing Authorisation Application 57 tesetaxel 57 LymphoStat B 57 Amplimexon 57 plus prednisone 57 Fibrillex TM 57 Orphan Drug designation 57 Pemetrexed 57 investigational 57 Telaprevir 57 lapatinib Tykerb 57 DPP4 inhibitor 57 diabetic neuropathic pain 57 Paclitaxel 57 vidofludimus 57 paclitaxel carboplatin 57 Dabigatran etexilate 57 OncoVEX GM CSF 57 Feraheme 57 paclitaxel Taxol ® 57 Onbrez Breezhaler 57 VPRIV 57 Votrient 57 Relistor 57 bevacizumab 57 Neulasta ® 57 Yervoy 57 UVIDEM 57 Marketing Authorization Application MAA 57 Removab 57 omacetaxine 57 Dapagliflozin 57 Nimotuzumab 57 CYT# 57 Tyrima 57 motesanib 57 vernakalant 57 plus dexamethasone 57 Evoltra 57 Rhucin 57 ALKS 57 PREOS R 57 recurrent ovarian cancer 57 Pivotal Phase III 57 ZETIA 57 hematological malignancies 57 Triolex 57 infusional 5-FU/LV 57 histone deacetylase HDAC inhibitor 57 Phase Ib II 57 prGCD 57 Alimta pemetrexed 57 cabazitaxel 57 Mycamine 57 TEMODAR 57 Mycograb 57 CIMZIA TM 57 paclitaxel 57 topical NSAID 57 Zybrestat 57 Pixuvri 57 Neurodex 57 ABRAXANE ® 57 luliconazole 57 Xyrem ® 57 Targretin capsules 57 Sutent 57 docetaxel chemotherapy 57 Phase IIb clinical 57 pemetrexed 57 biologic therapy 56 ACTEMRA TM 56 BRIM2 56 Clavis Pharma 56 Gabapentin GR 56 hormone refractory prostate cancer 56 Phase IIb trials 56 INC# 56 nab paclitaxel 56 tremelimumab 56 Aptivus 56 SUTENT 56 cetuximab 56 eculizumab 56 Q#IR 56 bafetinib 56 NPSP# 56 pertuzumab 56 Denosumab 56 PEGINTRON 56 Apaziquone 56 ospemifene 56 RhuDex ® 56 Glufosfamide 56 fipamezole 56 TRANSDUR Sufentanil 56 YONDELIS R 56 refractory indolent non 56 Leukine 56 oxymorphone ER 56 TroVax 56 dose cohort 56 Davanat 56 Increlex TM 56 Picoplatin 56 placebo controlled Phase 56 pazopanib 56 Adenuric R 56 Restanza 56 virus HCV protease inhibitor 56 pivotal Phase 56 Atrasentan 56 QNEXA 56 cell lymphoma CTCL 56 trastuzumab DM1 56 Neuradiab 56 oncology indications 56 pegfilgrastim 56 Cubicin 56 BRAF inhibitor 56 Phase IIb clinical trials 56 MGCD# [002] 56 Atiprimod 56 CINTREDEKIN BESUDOTOX 56 drug Erbitux 56 Orapred ODT 56 Fludara ® 56 BEMA TM Fentanyl 56 lasofoxifene 56 ImClone Erbitux 56 ancrod 56 cancer immunotherapies 56 KNS # 56 Targeted Chemotherapy 56 Arzerra 56 Gliadel Wafer 56 Chrysalin 56 amifampridine phosphate 56 Avastin 56 ATL# [001] 56 Rebetol 56 Gemcitabine 56 metastatic colorectal cancer 56 elacytarabine 56 ThermoDox ® 56 confirmatory Phase III 56 Oxaliplatin 56 EndoTAG TM -1 56 darapladib 56 Viprinex 56 AGGRASTAT ® 56 PrevOnco 56 Pruvel 56 OMP designation 56 Emend 56 Prestara 56 gemcitabine cisplatin 56 cetrorelix 56 Pixantrone 56 metaglidasen 56 lumiliximab 56 aclidinium bromide 56 raltegravir 56 APPRAISE 56 ATryn R 56 Phase 2b study 56 anti EGFR antibody 56 Oncoscience AG 56 APTIVUS r 56 SCHWARZ PHARMA 56 PSN# [002] 56 cladribine 56 AzaSite 56 CNTO 56 Fx #A 56 ALIMTA 56 Aptivus ® 56 AZX# 56 Arranon 56 VAPRISOL 56 fostamatinib 56 Phase IIb trial 56 RDEA# 56 mifamurtide 56 GlycoPEG GCSF 56 VEGF Trap 56 FIRAZYR 56 dirucotide MBP# 56 Ethyol 56 SYCREST 56 COMFORT II 56 Vidaza azacitidine 56 fenofibric acid 56 Marketing Authorization Application 56 rilonacept 56 MAP# 56 Rebif ® 56 mitogen activated ERK kinase 56 Kepivance 56 evaluating satraplatin 56 Hyphanox 56 SCH # 56 Xcytrin R 56 fenofibrate 56 OXi# 56 SUMAVEL DosePro 56 Octreolin 56 BLA submission 56 PEG Interferon lambda 56 Loramyc ® 56 SCCHN 56 RAPAFLO 56 LE DT 56 Betaferon ® 56 HGS ETR2 56 MyVax 56 TREDAPTIVE 56 Erlotinib 56 Preos 56 oral cladribine 56 brentuximab vedotin SGN 56 SAR# [004] 56 MEK inhibitor RDEA# 56 metastatic melanoma 56 GALNS 56 Alvesco R 56 AZOR 56 orBec 56 imetelstat 56 Phase Ib clinical 56 canakinumab 56 DOXIL 56 Hepsera 56 oral antiviral 56 Lucanix R 56 ularitide 56 Antegren 56 Movectro 56 BLA filing 56 PANVAC VF 56 ecallantide 56 alfimeprase 56 drug ISA# 56 Helsinn Healthcare 56 EndoTAGTM 1 56 mRCC 56 Lupuzor 56 FOLFIRI 56 standard chemotherapy regimen 56 IMiDs 56 Cetrorelix 56 Remodulin 56 metastatic HRPC 56 RGB # 56 Ketotransdel 56 Zensana TM 56 Veronate 56 Phase 1b clinical 56 Cloretazine R VNP#M 56 indiplon capsules 56 ALN RSV# 55 HIV integrase inhibitor 55 non nucleoside HCV 55 Vernakalant 55 ANA# 55 MyVax R 55 pantoprazole 55 PegIntron 55 depsipeptide 55 fingolimod 55 MoxDuo IR 55 AVN# [001] 55 randomized Phase 55 PEG PAL 55 plus gemcitabine 55 indibulin 55 Eloxatin ® 55 Rituxan 55 octreotide implant 55 Multaq R 55 Adentri 55 surrogate endpoint 55 BARACLUDE R 55 LibiGel ® 55 Exforge 55 Delcath PHP System 55 natalizumab 55 BLP# Liposome Vaccine 55 iclaprim 55 farletuzumab 55 Sanofi Aventis Taxotere 55 Rajesh C. Shrotriya 55 CDP# 55 CYCLOSET 55 L MTP PE 55 successfully commercialize Iluvien 55 Xgeva 55 Heplisav 55 KRN# 55 Phase III trials 55 Genentech Roche 55 Acetavance 55 ORENCIA ® 55 AZD# 55 evaluable patients 55 Camptosar ® 55 Cetuximab Erbitux 55 HUMIRA 55 Eligard 55 ONCASPAR 55 CYC# 55 vascular disrupting agent 55 ProSavin 55 davunetide 55 EndoTAG TM 55 Albuferon 55 Advagraf 55 XmAb# 55 Eloxatin 55 SUTENT ® 55 interferon alfa 55 visilizumab 55 bortezomib Velcade R 55 Esbriet 55 Doxil 55 Tyzeka 55 Onrigin 55 anticancer agent 55 Onsolis 55 vosaroxin 55 maraviroc 55 hoFH 55 sBLA 55 PROVIGIL 55 ADVEXIN clinical 55 rituximab 55 POSIDUR 55 Peginterferon alfa 2b 55 Betaferon 55 Virulizin ® 55 phase Ib 55 Phase IIa clinical 55 intravenous acetaminophen 55 Fibrin Pad 55 Tostrex 55 Syncria 55 MAXY G# 55 Specifid 55 Peg IFN 55 Renvela 55 PrevOnco ™ 55 incyclinide 55 opioid induced bowel dysfunction 55 samalizumab 55 Aromasin 55 OZURDEX ® 55 Cleviprex TM clevidipine 55 Zenvia ™ 55 TASQ 55 pegloticase 55 ofatumumab HuMax CD# 55 multicenter Phase 55 DCVax R Brain 55 Campath ® 55 liposomal formulation 55 betrixaban 55 mycophenolate mofetil 55 refractory gout 55 darunavir 55 DC Bead 55 Vilazodone 55 dacarbazine 55 evaluating tivozanib 55 ATryn ® 55 Rituxan rituximab 55 posaconazole 55 ACTEMRA 55 IV APAP 55 BR.# 55 metastatic hormone refractory 55 ACZ# 55 APTIVUS 55 Urocidin TM 55 Treximet 55 Certriad 55 LHRH antagonist 55 SUCCEED trial 55 Xyzal 55 danoprevir 55 REBETOL combination therapy 55 investigational humanized monoclonal antibody 55 SPRYCEL ® 55 interferon gamma 1b 55 ARIKACE 55 Golimumab 55 BEMA Fentanyl 55 Santhera 55 PI3K/Akt pathway inhibitor 55 JANUVIA 55 Vertex telaprevir 55 ONGLYZA ™ 55 IIa trial 55 Phase 1b trial 55 atrasentan 55 clodronate 55 Ontak 55 capecitabine 55 Vasovist 55 Phase III 55 Prochymal 55 Chemophase 55 satraplatin Phase 55 BCX# 55 Tekamlo 55 APD# 55 oral prodrug 55 Junovan TM 55 Phase IIb 55 FOLFOX4 55 PEG Intron 55 NEBIDO R 55 Vimpat ® lacosamide 55 casopitant 55 heterozygous FH 55 GLPG# 55 darinaparsin 55 FUZEON 55 Aplidin 55 NSCLC 55 antiplatelet agent 55 clinical trial 55 KALBITOR 55 DCVax ® Brain 55 Ilaris 55 cangrelor 55 NP2 Enkephalin 55 Novartis Zometa 55 integrase inhibitor 55 PNP inhibitor 55 comparator arm 55 Linjeta TM